Germany's Disposable E-Cigarette Sales Expected to Soar.

Mar.13.2023

Germany's Disposable E-Cigarette Sales Expected to Soar.

500万支/月，增幅40%，德国一次性电子烟销量将持续上涨至800万支。

According to a German environmental organization, the monthly sales of disposable e-cigarettes in Germany are estimated to reach 5 million units by 2023, and the trend is increasing.

The environmental group also stated that sales of disposable e-cigarettes in Germany increased by 40% compared to last year, and it is expected that monthly sales will reach 8 million units in the future.

Related reading:

Yueke International to establish long-term presence in Germany, partnering with over 2,000 retailers in the first year.

Reference:

The German Federal Council approves a ban on disposable e-cigarettes.

#North America #United States #Market #Alemania #Disposable e-cigarettes #E-cigarette #E-cigarettes and Tobacco

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.

Nov.10 by 2FIRSTS.ai

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

According to The Guardian, the British Museum has ended its 15-year sponsorship with Japan Tobacco International after government inquiries into whether the deal breached WHO tobacco-control rules. Critics had long opposed the partnership, while the museum said sponsorship remains essential for its financial stability and public access.

Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October

Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October

The Tuscaloosa, Alabama, City Council is considering imposing a local tax on e-cigarette products to meet a state bill deadline. Alabama Act 2025-377, signed into law in May, plans to impose a $0.10 per milliliter state excise tax on e-cigarette products starting in October.

Sep.25 by 2FIRSTS.ai

UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation

UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation

UK police have carried out a nationwide crackdown under Operation Machinize 2, targeting illegal vapes, counterfeit goods, and grey-market businesses. Raids on more than 2,700 premises led to 924 arrests and the seizure of 111,000 illegal vapes, 70kg of cannabis, 4.5m cigarettes, and £10.7m in proceeds.

Nov.11 by 2FIRSTS.ai

PMI Launches VEEV E-Cigarette in South Africa, Expanding Access to Smoke-Free Alternatives

PMI Launches VEEV E-Cigarette in South Africa, Expanding Access to Smoke-Free Alternatives

Philip Morris International's South Africa branch launches e-cigarette product Veev, making South Africa one of 20 countries with PMI's smoke-free products.

Oct.13 by 2FIRSTS.ai

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Sep.25 by 2FIRSTS.ai

Related Topics

News

Related Read

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October

Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October

UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation

UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation

PMI Launches VEEV E-Cigarette in South Africa, Expanding Access to Smoke-Free Alternatives

PMI Launches VEEV E-Cigarette in South Africa, Expanding Access to Smoke-Free Alternatives

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

FOLLOW US ON SOCIAL MEDIA

Contact: info@2firsts.com

Stay up to date.

Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.

sign up

© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.

2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.

This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com

English

English

中文